361 related articles for article (PubMed ID: 20495188)
21. Cardiotoxicity in signal transduction therapeutics: erbB2 antibodies and the heart.
Schneider JW; Chang AY; Rocco TP
Semin Oncol; 2001 Oct; 28(5 Suppl 16):18-26. PubMed ID: 11706392
[TBL] [Abstract][Full Text] [Related]
22. Microarray and Co-expression Network Analysis of Genes Associated with Acute Doxorubicin Cardiomyopathy in Mice.
Wei SN; Zhao WJ; Zeng XJ; Kang YM; Du J; Li HH
Cardiovasc Toxicol; 2015 Oct; 15(4):377-93. PubMed ID: 25575753
[TBL] [Abstract][Full Text] [Related]
23. MiRNA-30e mediated cardioprotection of ACE2 in rats with Doxorubicin-induced heart failure through inhibiting cardiomyocytes autophagy.
Lai L; Chen J; Wang N; Zhu G; Duan X; Ling F
Life Sci; 2017 Jan; 169():69-75. PubMed ID: 27633839
[TBL] [Abstract][Full Text] [Related]
24. The role of endothelial autocrine NRG1/ERBB4 signaling in cardiac remodeling.
Dugaucquier L; Feyen E; Mateiu L; Bruyns TAM; De Keulenaer GW; Segers VFM
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H443-H455. PubMed ID: 32618511
[TBL] [Abstract][Full Text] [Related]
25. miR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway.
Yin Z; Zhao Y; Li H; Yan M; Zhou L; Chen C; Wang DW
Aging (Albany NY); 2016 Jan; 8(1):192-207. PubMed ID: 26837315
[TBL] [Abstract][Full Text] [Related]
26. MiR-21 Protected Cardiomyocytes against Doxorubicin-Induced Apoptosis by Targeting BTG2.
Tong Z; Jiang B; Wu Y; Liu Y; Li Y; Gao M; Jiang Y; Lv Q; Xiao X
Int J Mol Sci; 2015 Jun; 16(7):14511-25. PubMed ID: 26132560
[TBL] [Abstract][Full Text] [Related]
27. Gene expression profiling identifies the novel role of immunoproteasome in doxorubicin-induced cardiotoxicity.
Zhao WJ; Wei SN; Zeng XJ; Xia YL; Du J; Li HH
Toxicology; 2015 Jul; 333():76-88. PubMed ID: 25896364
[TBL] [Abstract][Full Text] [Related]
28. Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase-induced cardiomyopathy: involvement of mitofusin-2.
McLaughlin D; Zhao Y; O'Neill KM; Edgar KS; Dunne PD; Kearney AM; Grieve DJ; McDermott BJ
Br J Pharmacol; 2017 Nov; 174(21):3677-3695. PubMed ID: 28261787
[TBL] [Abstract][Full Text] [Related]
29. Impaired NF-κB signalling underlies cyclophilin D-mediated mitochondrial permeability transition pore opening in doxorubicin cardiomyopathy.
Dhingra R; Guberman M; Rabinovich-Nikitin I; Gerstein J; Margulets V; Gang H; Madden N; Thliveris J; Kirshenbaum LA
Cardiovasc Res; 2020 May; 116(6):1161-1174. PubMed ID: 31566215
[TBL] [Abstract][Full Text] [Related]
30. Heterozygous knockout of neuregulin-1 gene in mice exacerbates doxorubicin-induced heart failure.
Liu FF; Stone JR; Schuldt AJ; Okoshi K; Okoshi MP; Nakayama M; Ho KK; Manning WJ; Marchionni MA; Lorell BH; Morgan JP; Yan X
Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H660-6. PubMed ID: 15833803
[TBL] [Abstract][Full Text] [Related]
31. Circ-SKA3 Enhances Doxorubicin Toxicity in AC16 Cells Through miR-1303/TLR4 Axis.
Li B; Cai X; Wang Y; Zhu H; Zhang P; Jiang P; Yang X; Sun J; Hong L; Shao L
Int Heart J; 2021 Sep; 62(5):1112-1123. PubMed ID: 34544967
[TBL] [Abstract][Full Text] [Related]
32. miR-451 Silencing Inhibited Doxorubicin Exposure-Induced Cardiotoxicity in Mice.
Li J; Wan W; Chen T; Tong S; Jiang X; Liu W
Biomed Res Int; 2019; 2019():1528278. PubMed ID: 31355248
[TBL] [Abstract][Full Text] [Related]
33. Exosomal LncRNA-NEAT1 derived from MIF-treated mesenchymal stem cells protected against doxorubicin-induced cardiac senescence through sponging miR-221-3p.
Zhuang L; Xia W; Chen D; Ye Y; Hu T; Li S; Hou M
J Nanobiotechnology; 2020 Oct; 18(1):157. PubMed ID: 33129330
[TBL] [Abstract][Full Text] [Related]
34. Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis.
Roca-Alonso L; Castellano L; Mills A; Dabrowska AF; Sikkel MB; Pellegrino L; Jacob J; Frampton AE; Krell J; Coombes RC; Harding SE; Lyon AR; Stebbing J
Cell Death Dis; 2015 May; 6(5):e1754. PubMed ID: 25950484
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-1 signaling mediates acute doxorubicin-induced cardiotoxicity.
Zhu J; Zhang J; Zhang L; Du R; Xiang D; Wu M; Zhang R; Han W
Biomed Pharmacother; 2011 Oct; 65(7):481-5. PubMed ID: 22000485
[TBL] [Abstract][Full Text] [Related]
36. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
van Almen GC; Swinnen M; Carai P; Verhesen W; Cleutjens JP; D'hooge J; Verheyen FK; Pinto YM; Schroen B; Carmeliet P; Heymans S
J Mol Cell Cardiol; 2011 Sep; 51(3):318-28. PubMed ID: 21624372
[TBL] [Abstract][Full Text] [Related]
37. Neuregulin in cardiac hypertrophy in rats with aortic stenosis. Differential expression of erbB2 and erbB4 receptors.
Rohrbach S; Yan X; Weinberg EO; Hasan F; Bartunek J; Marchionni MA; Lorell BH
Circulation; 1999 Jul; 100(4):407-12. PubMed ID: 10421602
[TBL] [Abstract][Full Text] [Related]
38. The Tumor-Suppressive Human Circular RNA CircITCH Sponges miR-330-5p to Ameliorate Doxorubicin-Induced Cardiotoxicity Through Upregulating SIRT6, Survivin, and SERCA2a.
Han D; Wang Y; Wang Y; Dai X; Zhou T; Chen J; Tao B; Zhang J; Cao F
Circ Res; 2020 Jul; 127(4):e108-e125. PubMed ID: 32392088
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-129-1-3p protects cardiomyocytes from pirarubicin-induced apoptosis by down-regulating the GRIN2D-mediated Ca
Li Q; Qin M; Tan Q; Li T; Gu Z; Huang P; Ren L
J Cell Mol Med; 2020 Feb; 24(3):2260-2271. PubMed ID: 31957170
[TBL] [Abstract][Full Text] [Related]
40. Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction.
Li S; Wang W; Niu T; Wang H; Li B; Shao L; Lai Y; Li H; Janicki JS; Wang XL; Tang D; Cui T
Oxid Med Cell Longev; 2014; 2014():748524. PubMed ID: 24895528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
